Do you need to control and assess potential gluten cross-contamination at your lab by using a fast and reliable tool? The new SENSIStrip Gluten lateral flow test from Eurofins Technologies can meet all of your gluten testing requirements! Join our webinar on the 15th of September to learn more about our new and easy-to-use strip test for gluten risk assessment, which also offers the possibility of interpreting the results with a standalone reader, providing more accurate results.
Register to the webinar today: Registration link for on-site gluten testing webinar
Key Topics of the Webinar
Eurofins Technologies is glad to announce the launch of its GSD NovaType Select SARS-CoV-2 (RUO) assay family. This group of assays has been developed in response to continuously developing concerning mutations of the SARS-CoV-2 virus that lead to constantly emerging new virus variants with increased transmissibility, virulence or resistance to immune response.
The GSD NovaType Select assay family provides customers with the ability to specifically screen for mutations most concerning at a given time, and rapidly switch to or add other mutations when necessary. The GSD NovaType Select family of assays will be constantly updated when new variants arise to detect specific mutations.
Earlier this year, we launched our new and improved SENSIStrip Lateral Flow Device product line for allergen detection in foodstuffs and in environmental samples. These products allow a fast and reliable detection of allergens that must be labeled on packaged food products, and support efficient cleaning control monitoring.
We are pleased to announce that a gluten rapid test has now been added to this portfolio. With low detection limits and only a few minutes of incubation time, this solution helps laboratories with providing and adequate control at different stages of the food manufacturing process, across food matrices, rinse water and equipment.
Are you interested in a special launch offer? Click here: Gluten LFD Launch Campaign
Eurofins Abraxis, a developer, manufacturer and supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent assay) for the detection of Glyphosate, Eurofins Abraxis Glyphosate ELISA Kit, has been granted AOAC Research Institute Performance Tested Methods (PTM) status (AOAC Cert. No. 072104) for use with whole grain durum wheat, whole grain oats, oat groats, dried yellow peas, and dried red lentils. The Eurofins Abraxis Glyphosate ELISA Kit is the first rapid method to receive this certification status.
First introduced in the 1970’s, glyphosate is the most widely applied herbicide for controlling grasses and broadleaf weeds in both agricultural and non-crop environments. Its widespread adoption coincided with the introduction of crops genetically modified to tolerate glyphosate, allowing farmers to target weeds while protecting their valuable crops. Recent consumer pressures have resulted in an increase in commodity testing for glyphosate throughout branded food manufacturing supply chains.
Eurofins Technologies announces the launch of its GSD NovaType III SARS-CoV-2 RT-PCR assay, developed for the rapid detection of SARS-CoV-2 variants of concern including B.1.617 (“India”), B.1.427/B.1.429 (“California/USA”), B.1.351 (“South Africa”) or P.1 (“Brazil”). The assay facilitates the identification of the relevant mutations E484Q, E484K and L452R in one reaction combined with the simultaneous discrimination from the S gene E484 wildtype variant. These mutations have been associated with reports of potential decreased efficacy of certain vaccines and an increase in the transmissibility of the virus.
Eurofins Technologies continues to develop a range of diagnostic solutions for COVID-19, particularly in response to the threat of emerging mutations. Today, we announce the launch of two new products: GSD NovaPrime® Plus SARS-CoV-2, a PCR test which can identify, in one reaction, key variants of concern including the UK variant; and GSD NovaType Select L452R (RUO) the first test of its type able to identify critical variants such as the Indian, USA and Californian variants. Eurofins Technologies will continue to invest in R&D to develop further reliable, high-quality testing solutions for the SARS-CoV-2 virus and its variants.
Earlier this year, we launched our new and improved Lateral Flow Device product line for allergen detection in foodstuffs and environmental samples. These products quickly detect allergens that must be labeled on packaged food products.
Our customers were pleased to discover the new devices, as this easy-to-use and quick method requires only a few minutes of incubation time, with low detection limits.
For the efficient monitoring of aflatoxin contamination, it is necessary to apply analytical kits capable to detect all the four aflatoxins B1, B2, G1 and G2, in an accurate and preferably fast manner.
H2AFLA is a new rapid ELISA kit for the detection of total aflatoxins B and G in different types of matrices. The kit is using an antibody with high cross-reactivity for the four forms of aflatoxins: measured in the absence of matrix at 50% inhibition, the cross-reactivity was 100% for aflatoxin B1, 92% for B2, 86% for G1 and 76% for G2.
Eurofins Technologies announces the launch of its GSD NovaType II, its upgraded RT-PCR kit for the identification of mutations associated with SARS-CoV-2 variants of concern.
The first GSD NovaType RT-PCR kit was launched in February 2021 and quickly supported health authorities in the detection of variants in more than 100,000 COVID-19 positive patients across Europe. The new GSD NovaType II kit can now detect the N501Y and E484K mutations common to most VOC (Variants Of Concern) and the K417N mutation (specific to B.1.351 first identified in South Africa), with high sensitivity.
Eurofins adds today virus variant monitoring capabilities to its commercially available SARS-CoV-2 stand-alone test kit portfolio. This new solution is also part of the Eurofins Covid-19 Sentinel™ and the SAFER@WORK™ program which provide an early warning of the presence of SARS-CoV-2 amongst large populations at a given site (e.g. a city, factories, education institutions, government and public service sites, nursing homes), before the virus spreads too broadly.
At those sites, wastewater and environmental surface testing, offered as part of the Eurofins COVID-19 Sentinel™ programme, can give an early indication of the presence of SARS-CoV-2 variants, therefore allowing for relevant containment measures in order to avoid an outbreak of the disease even before symptom onset, and now also identifying the involved virus variants.